J. Braun

发表

CT-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy: indication and follow-up with contrast-enhanced MRI.

B. Hamm, M. Taupitz, K. Wolf, 1996, Journal of computer assisted tomography.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

M. Dougados, D. M. van der Heijde, R. Landewé, 2009, Annals of the rheumatic diseases.

Radiologic diagnosis and pathology of the spondyloarthropathies.

J. Braun, J. Sieper, M. Bollow, 1998, Rheumatic diseases clinics of North America.

Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?

J. Braun, U. Kiltz, J. Zochling, 2008, Rheumatology.

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

M. Dougados, M. D. de Wit, F. Breedveld, 2011, Annals of the rheumatic diseases.

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

M. Dougados, B. Dijkmans, I. Olivieri, 2011, Annals of the rheumatic diseases.

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

M. Dougados, D. M. van der Heijde, R. Landewé, 2009, Annals of the rheumatic diseases.

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

M. Dougados, D. M. van der Heijde, D. Heijde, 2007, Annals of the rheumatic diseases.

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

M. Dougados, D. Heijde, A. Deodhar, 2013, Annals of the rheumatic diseases.

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

R. Landewé, T. Kvien, D. Baker, 2010 .

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

H. Zeidler, G. Burmester, G. Burmester, 2004, Annals of the rheumatic diseases.

ASAS/EULAR recommendations for the management of ankylosing spondylitis

M. Dougados, S. van der Linden, B. Dijkmans, 2005, Annals of the rheumatic diseases.

Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response.

S. Batsford, P. Wu, J. Braun, 1998, Arthritis and rheumatism.

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

D. M. van der Heijde, A. Deodhar, S. Visvanathan, 2008, Annals of the rheumatic diseases.

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

M. Dougados, D. M. van der Heijde, R. Landewé, 2013, Annals of the rheumatic diseases.

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases

J. Braun, J. Sieper, L. Neure, 2005, Annals of the rheumatic diseases.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab

J. Braun, J. Brandt, J. Listing, 2005 .

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept

J. Braun, J. Brandt, J. Listing, 2005, Annals of the rheumatic diseases.

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.

H. Zeidler, G. Burmester, W. Golder, 2003, Arthritis and rheumatism.

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

H. Zeidler, W. Golder, A. Krause, 2002, The Lancet.

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

J. Braun, J. Sieper, M. Bollow, 1995, Arthritis and rheumatism.

Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging.

K. Wolf, B. Hamm, J. Braun, 1995, Radiology.

Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients.

J. Sieper, J. Braun, M. Bollow, 1994, Arthritis and rheumatism.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

M. Dougados, B. Dijkmans, I. Olivieri, 2009, Annals of the rheumatic diseases.

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Andreas Krause, M. Baumgaertner, H. Zeidler, 2006, Annals of the rheumatic diseases.

Successful use of anakinra to treat refractory Schnitzler's syndrome.

N. Sepp, J. Braun, F. Dybowski, 2008, Clinical and experimental rheumatology.

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

J. Braun, J. Brandt, J. Listing, 2003, Arthritis and rheumatism.

Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?

J. Braun, X. Baraliakos, J. Braun, 2015, RMD Open.

Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis.

P. Wu, J. Braun, J. Sieper, 1994, Annals of the rheumatic diseases.

Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides

J. Braun, J. Brandt, J. Sieper, 2005, Scandinavian journal of rheumatology.

Report on the Fourth International Workshop on Reactive Arthritis.

G. Kingsley, J. Braun, J. Sieper, 2000, Arthritis and rheumatism.

Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis

S. van der Linden, D. M. van der Heijde, A. Boonen, 2005, Annals of the rheumatic diseases.

The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).

A. Calin, S. Brophy, P. Andlin-Sobocki, 2004, Rheumatology.

Severe lupus crisis with agranulocytosis and anuric renal failure due to a mesangial lesion (WHO IIB)--successful treatment with cyclophosphamide pulse followed by plasmapheresis.

A. Schwarz, F. Keller, J. Heitz, 1991, British journal of rheumatology.

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

J. Braun, J. Brandt, J. Listing, 2004, Annals of the rheumatic diseases.